Suvanza Pharma, LLC (SUVZ)
- Previous Close
0.0001 - Open
0.0001 - Bid --
- Ask --
- Day's Range
0.0001 - 0.0001 - 52 Week Range
0.0001 - 0.0500 - Volume
1,147 - Avg. Volume
0 - Market Cap (intraday)
2,015 - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-0.7300 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Suvanza Pharma, LLC operates as an early-stage biotechnology corporation and engages in the development of the skin drug delivery system, RapiDerm for dermatologic diseases. Suvanza Pharma, LLC was formerly known as Hamilton PNG and changed its name to Suvanza Pharma, LLC in March 2010. The company was founded in 2004 and is based in Miami Beach, Florida.
www.suvanza.comRelated News
Performance Overview: SUVZ
Trailing total returns as of 4/25/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: SUVZ
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: SUVZ
Valuation Measures
Market Cap
--
Enterprise Value
--
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
-0.12
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
--
Diluted EPS (ttm)
-0.7300
Balance Sheet and Cash Flow
Total Cash (mrq)
--
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--
Company Insights: SUVZ
SUVZ does not have Company Insights